ORIGINAL RESEARCH
Published on 16 Aug 2022
Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation
doi 10.3389/fimmu.2022.803229
- 3,300 views
- 7 citations
- Frontiers in Immunology
- Multiple Sclerosis and Neuroimmunology
- Research Topics
- Reassessing the Immune System Contribution in Multiple Sclerosis: Therapeutic Target, Biomarkers of Disease and Immune Pathogenesis
Reassessing the Immune System Contribution in Multiple Sclerosis: Therapeutic Target, Biomarkers of Disease and Immune Pathogenesis
29k
Total downloads
91k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 21 Mar 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
doi 10.3389/fimmu.2022.842354
- 2,108 views
- 2 citations
ORIGINAL RESEARCH
Published on 28 Feb 2022
Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up
doi 10.3389/fimmu.2022.818325
- 2,032 views
- 8 citations
ORIGINAL RESEARCH
Published on 24 Feb 2022
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis
doi 10.3389/fneur.2022.820256
- 1,708 views
- 10 citations
BRIEF RESEARCH REPORT
Published on 07 Feb 2022
Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients
doi 10.3389/fimmu.2022.750660
- 4,888 views
- 6 citations
BRIEF RESEARCH REPORT
Published on 01 Feb 2022
CCR6 and CXCR6 Identify the Th17 Cells With Cytotoxicity in Experimental Autoimmune Encephalomyelitis
doi 10.3389/fimmu.2022.819224
- 6,474 views
- 21 citations
ORIGINAL RESEARCH
Published on 20 Jan 2022
Constructing a Multiple Sclerosis Diagnosis Model Based on Microarray
doi 10.3389/fneur.2021.721788
- 1,566 views
- 4 citations
ORIGINAL RESEARCH
Published on 13 Jan 2022
Tim-3 Relieves Experimental Autoimmune Encephalomyelitis by Suppressing MHC-II
doi 10.3389/fimmu.2021.770402
- 3,102 views
- 12 citations
ORIGINAL RESEARCH
Published on 16 Dec 2021
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
doi 10.3389/fimmu.2021.778204
- 2,980 views
- 7 citations
ORIGINAL RESEARCH
Published on 14 Dec 2021
Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients – An In Vitro Study
doi 10.3389/fimmu.2021.743010
- 2,920 views
- 2 citations
ORIGINAL RESEARCH
Published on 08 Dec 2021
Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis
doi 10.3389/fimmu.2021.770679
- 2,217 views
- 9 citations
ORIGINAL RESEARCH
Published on 07 Dec 2021
Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis
doi 10.3389/fimmu.2021.753929
- 10,015 views
- 26 citations
Published in
Frontiers in Immunology
- Multiple Sclerosis and Neuroimmunology
Participating Journals
Frontiers in Neurology
- 2.7 impact factor
- 4.9 citescore
Impact
- 91kTopic views
- 60kArticle views
- 29kArticle downloads